| Indicators | Browse All

Impact BioMedical Inc. (IBO)

Healthcare | Biotechnology | Houston, United States | NYSE American
3.98 USD -0.05 (-1.241%) ⇩ (Oct. 13, 2026, 4 p.m. EDT)

Short-term:⯪☆☆☆☆Long-term:⯪☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 1:08 a.m. EDT

The immediate outlook is severely bearish as the stock has collapsed from its recent highs, trading well below both the fifty-day and two-hundred-day moving averages, indicating significant downward momentum. While the company recently announced a merger with Dr. Ashley's Ltd., which often spurs speculative buying, the underlying financial reality is dire: revenue has contracted by nearly 57%, operating margins are deeply negative at -234%, and the balance sheet is fragile with a current ratio of only 0.156 and minimal cash reserves relative to operations. The long-term picture is equally bleak given the massive 60% decline over the last year and the lack of any dividend history to provide income or stability. This appears to be a distressed biotech play reliant entirely on merger speculation rather than sustainable business fundamentals.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.057764
MSTL0.073529
AutoETS0.076836
AutoTheta0.113356

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 20%
H-stat 13.74
Ljung-Box p 0.000
Jarque-Bera p 0.001
Excess Kurtosis 0.79
Attribute Value
Sector Healthcare
Debt to Equity Ratio 9.492
Revenue per Share 0.006
Market Cap 34,003,844
Trailing P/E 0.36
Beta 2.73
Profit Margins 2260.00%
Website https://www.impactbiomedinc.com

Info Dump

Attribute Value
52 Week Change -0.48063624
Address1 1,400 Broadfield Blvd.
Address2 Suite 130
All Time High 78.101265
All Time Low 4.0
Ask 0.0
Ask Size 100
Average Daily Volume10 Day 11,110
Average Daily Volume3 Month 11,953
Average Volume 11,953
Average Volume10Days 11,110
Beta 2.733
Bid 0.0
Bid Size 100
Book Value 1.26
City Houston
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 3.98
Current Ratio 0.156
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 4.04
Day Low 3.84
Debt To Equity 9.492
Display Name Impact BioMedical
Dividend Yield 0.0
Ebitda -3,952,000
Ebitda Margins 0.0
Enterprise To Ebitda -9.423
Enterprise To Revenue 1,064.004
Enterprise Value 37,240,140
Eps Trailing Twelve Months 11.11
Esg Populated 0
Exchange ASE
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 5.750805
Fifty Day Average Change -1.7708049
Fifty Day Average Change Percent -0.30792296
Fifty Two Week Change Percent -48.063625
Fifty Two Week High 10.506329
Fifty Two Week High Change -6.5263286
Fifty Two Week High Change Percent -0.6211807
Fifty Two Week Low 3.84
Fifty Two Week Low Change 0.1400001
Fifty Two Week Low Change Percent 0.036458362
Fifty Two Week Range 3.84 - 10.506329
Financial Currency USD
First Trade Date Milliseconds 1,726,493,400,000
Float Shares 910,337
Free Cashflow 1,016,875
Full Exchange Name NYSE American
Full Time Employees 2
Fullday Change -0.1800003
Fullday Change Percent -4.4665084
Fullday Price 3.9
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Gross Profits -389,000
Has Pre Post Market Data 1
Held Percent Insiders 0.89015996
Held Percent Institutions 0.03558
Implied Shares Outstanding 8,543,679
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,790,121,600
Last Split Factor 79:1000
Long Business Summary Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc
Long Name Impact BioMedical Inc.
Market us_market
Market Cap 34,003,844
Market State PRE
Max Age 86,400
Message Board Id finmb_644355879
Most Recent Quarter 1,782,777,600
Net Income To Common 791,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 56,644,591
Open 4.11
Operating Cashflow -508,000
Operating Margins -234.0
Payout Ratio 0.0
Phone 281 415 6576
Pre Market Change -0.07999992
Pre Market Change Percent -2.0100484
Pre Market Price 3.9
Pre Market Time 1,791,964,917
Previous Close 4.03
Price Hint 4
Price To Book 3.1587303
Price To Sales Trailing12 Months 971.5384
Profit Margins 22.6
Quick Ratio 0.005
Quote Source Name Delayed Quote
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.0500002
Regular Market Change Percent -1.2407
Regular Market Day High 4.04
Regular Market Day Low 3.84
Regular Market Day Range 3.84 - 4.04
Regular Market Open 4.11
Regular Market Previous Close 4.03
Regular Market Price 3.98
Regular Market Time 1,791,921,600
Regular Market Volume 9,431
Return On Assets -0.17787
Return On Equity 0.23462
Revenue Growth -0.571
Revenue Per Share 0.006
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 8,543,679
Shares Percent Shares Out 0.0034999999
Shares Short 30,169
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 42,645
Short Name Impact BioMedical, Inc.
Short Percent Of Float 0.0324
Short Ratio 1.13
Source Interval 15
State TX
Symbol IBO
Total Cash 10,000
Total Cash Per Share 0.001
Total Debt 0
Total Revenue 35,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 11.11
Trailing P E 0.35823584
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 6.4721317
Two Hundred Day Average Change -2.4921317
Two Hundred Day Average Change Percent -0.38505578
Type Disp Equity
Volume 9,431
Website https://www.impactbiomedinc.com
Zip 77,084